卵巢肿瘤保留生育力现状  

Status of fertility preservation in ovarian cancer

作　　者：徐菲[1] 吴小华[1] XU Fei;WU Xiao-hua(Department of Gynecologic Oncology,Fudan University Shanghai Cancer Center,Shanghai 200032,China)

机构地区：[1]复旦大学附属肿瘤医院,上海200032

出　　处：《中国实用妇科与产科杂志》2022年第11期1074-1079,共6页Chinese Journal of Practical Gynecology and Obstetrics

基　　金：国家自然科学基金(81972431)。

摘　　要：卵巢肿瘤的发病率逐步年轻化,3%~14%的患者在育龄期诊断,在ⅠA~ⅠB期小于44岁女性的5年生存率高达91.2%。因此,在不影响生存率的情况下保留患者生育功能愈来愈重要。文章主要对卵巢肿瘤保留生育功能的手术治疗和辅助生殖技术的现状进行阐述。The age of women diagnosed with ovarian cancer is gradually getting younger,3%to 14%of patients are diagnosed at reproductive age,and the overall 5-year survival rate of women younger than 44years old in stages IA to IB is as high as 91.2%.Therefore,the treatment that preserves the reproductive function of patients without affecting the survival rate is increasingly important.This article mainly describes the current status of fertility-sparing surgical treatment and assisted reproductive technology for ovarian malignant tumors.

关 键 词：卵巢肿瘤 保留生育功能手术 辅助生殖技术 

分 类 号：R737.3[医药卫生—肿瘤]